Interaction of transforming growth factor β (TGFβ) with proteinase 3

Advances in Experimental Medicine and Biology

Volumn 421, Issue , 1997, Pages 307-313

  Kekow, J ^a   Csernok, E ^b   Szymkowiak, C ^b   Gross, W L ^b  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CATHEPSIN G; INTERLEUKIN 8; LEUKOCYTE ELASTASE; LYSOSOME ENZYME; NEUTROPHIL CYTOPLASMIC ANTIBODY; PROTEINASE; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; AUTOIMMUNITY; CHURG STRAUSS SYNDROME; CONTROLLED STUDY; DEGRANULATION; ETIOLOGY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; LEUKOCYTE MEMBRANE; MAJOR CLINICAL STUDY; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; SYSTEMIC VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 0030792743     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4757-9613-1_40     Document Type: Article

References (19)

1. Wahl, S.M. 1994. Transforming growth factor beta: the good, the bad, and the ugly. J. Exp. Med. 180:1587-1590.
2. Kekow, J. and G.J. Wiedemann. 1995. Transforming growth factor β: A cytokine with multiple actions in oncology and potential clinical applications (Review). Int. J. Oncol. 7:177-182.
3. Allen, J.B., C.L. Manthey, A.R. Hand, K. Ohura, L. Ellingsworth, and S.M. Wahl 1990. Rapid onset synovial inflammation and hyperplasia induced by transforming growth factor β. J. Exp. Med. 171:231-247.
4. Brandes, M.E., J.B. Allen, Y. Ogawa, and S.M. Wahl. 1991. TGF-β1 suppresses leukocyte recruitment and synovial inflammation in experimental arthritis. J. Clin. Invest. 87:1108-1113.
5. Szymkowiak, C., I. Mons, W.L. Gross, and J. Kekow. 1995. Determination of transforming growth factor β 2 determination in human blood samples by ELISA. J. Immunol. Methods 184:263-271.
6. Gross, W.L., E. Csernok, and B.K. Flesch. 1993. 'Classic' anti-neurophil cytoplasmic autoantibodies (cANCA), 'Wegener's autoantigen' and their immunopathogenic role in Wegener's granulomatosis. Autoimmunity 6:171-184.
7. Gross, W.L., W.H. Schmitt, and E. Csernok. 1993. ANCA and associated diseases: Immunodiagnostic and pathogenic aspects. Clin. Exp. Immunol. 91:1-12.
8. Lyons, R.M., L.E. Gentry, A.F. Purchio, and H.L. Moses. 1990. Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin. J Cell Biol. 110:1361-1367.
9. Kekow, J. and W.L. Gross. 1997. Immunologic assessments. In: Diagnostics of vascular diseases. Priciples and technology. P. Lanzer and M. Lipton. editors. Berlin, Springer. 226-236.
10. Kekow, J., W. Wachsman, J.A. Mc Cutchan, W.L. Gross, M. Zachariah, D.A. Carson, and M. Lotz. 1991 TGF-β and suppression of humoral immune responses in HIV infection. J. Clin. Invest. 87:1010-1016.
11. Kekow, J., W. Wachsman, J.A. MacCutchan, M. Cronin, D.A. Carson, and M. Lotz. 1990. Transforming growth factor β and noncytopathic mechanisms of immunodeficiency in human immunodeficiency virus infection. Proc. Natl. Acad. Sci. U. S. A. 87:8321-8325.
12. Csernok, E., J. Lüdemann, W.L. Gross, and D.F. Bainton. 1990. Ultrastructural localization of proteinase 3. the target antigen of anti-cytoplasmic antibodies circulating in Wegener's granulomatosis. Am. J Pathol. 137:1113-1120.
13. Csernok, E., M. Ernst, W. Schmitt, D.F. Bainton, and W.L. Gross. 1994. Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivo. Clin. Exp. Immunol. 95:244-250.
14. Leid, R.W., B.E. Ballieux, I. van der Heijden, C. Kleyburg van der Keur, E.C. Hagen, L.A. van Es. F.J. Van der Woude, and M.R. Daha. 1993. Cleavage and inactivation of human C1 inhibitor by the human leukocyte proteinase, proteinase 3. Eur. J. Immunol. 23:2939-2944.
15. Kekow, J., C. Szymkowiak, and W.L. Gross. 1992 Involvement of cytokines in granuloma formation within primary systemic vasculitis. In: New advances on cytokines. S. Romagnani, T.R. Mosmann, and A.K. Abbas, editors. New York, Raven Press. 341-348.
16. Deguchi, Y. N. Shibata, and S. Kishimoto. 1990. Enhanced expression of the tumour necrosis factor/cachectin gene in peripheral blood mononuclear cells from patients with systemic vasculitis. Clin. Exp Immunol. 81:311-314.
17. Gross, W.L., S. Hauschild, and N. Mistry. 1994. The clinical relevance of ANCA in vasculitis. Clin. Exp. Immunol. 93:7-11.
18. McCartney Francis, N.L. and S.M. Wahl. 1994. Transforming growth factor beta: a matter of life and death. J. Leukoc. Biol. 55:401-409.
19. Border, W.A., N.A. Noble, T. Yamamoto, J.R. Harper, Y. Yamaguchi, M.D Pierschbacher, and E. Ruoslahti. 1992. Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease. Nature 360:361-364.